Magnesium Sulfate

Magnesium sulfate is ordered for both preeclampsia and preterm labor, but the clinical goal is completely different in each case — confusing them changes everything about your nursing priorities.

Magnesium sulfate (MgSO4) is a central nervous system depressant that reduces neuromuscular excitability. In preeclampsia and eclampsia, it is the first-line drug for seizure prophylaxis — not blood pressure control. It works by stabilizing neuronal cell membranes and raising the seizure threshold, preventing the tonic-clonic convulsions of eclampsia that threaten both maternal and fetal life. The therapeutic serum magnesium level for seizure prevention is 4–7 mEq/L (4.8–8.4 mg/dL). A typical protocol is a 4–6 g IV loading dose over 15–30 minutes, followed by a maintenance infusion of 1–2 g/hour. In preterm labor, MgSO4 is used as a tocolytic to relax uterine smooth muscle, slowing or stopping contractions to buy time — usually 24–48 hours — for antenatal corticosteroids to promote fetal lung maturity. It also provides fetal neuroprotection when delivery before 32 weeks is anticipated, reducing the risk of cerebral palsy. The underlying mechanism is related in both uses — magnesium competes with calcium at the neuromuscular junction, decreasing muscle contractility — but the specific pathways overlap rather than being identical, and the clinical rationale differs entirely.

Key Distinctions

MgSO4 prevents seizures in preeclampsia; it does not treat hypertension. Students confuse this constantly — antihypertensives like labetalol or hydralazine lower BP, while MgSO4 protects the brain. Don't confuse the tocolytic role (relaxing the uterus) with the seizure prophylaxis role — same drug, different indication, different priority assessments. MgSO4 for preterm labor is a short-term bridge, not a long-term tocolytic.

Clinical Pearl

Mag is for the brain, not the blood pressure. If the provider orders MgSO4 for preeclampsia and the BP is still 170/110, expect a separate antihypertensive order.

Toxicity Recognition

Magnesium sulfate toxicity follows a dose-dependent, predictable sequence. Therapeutic serum levels for seizure prophylaxis are 4–7 mEq/L. The first warning sign is loss of deep tendon reflexes (DTRs), which disappears around 7–10 mEq/L. This is the clinical tripwire — if patellar reflexes are absent, the infusion must stop immediately. As levels climb to 10–13 mEq/L, respiratory depression sets in; respiratory rate drops below 12 breaths/min. Above 15 mEq/L, cardiac conduction fails — bradycardia, widened QRS, and cardiac arrest become the threat. The progression is always reflexes first, then respirations, then cardiac. You don't need a serum level to recognize early toxicity — absent DTRs and slowing respirations are your bedside alarms. Urine output below 30 mL/hr signals impaired renal clearance because magnesium is excreted entirely by the kidneys; oliguria means the drug is accumulating even if the dose hasn't changed. Other signs include flushing, lethargy, slurred speech, and muscle weakness. The patient may describe feeling heavy or unable to lift the arms. These subjective complaints are real warnings, not anxiety.

Key Distinctions

Don't confuse magnesium toxicity (absent reflexes, respiratory depression, hypotension) with eclamptic seizure progression (hyperreflexia, clonus, hypertension) — they move in opposite directions. Students mix up the order: reflexes disappear before respirations drop. Respiratory depression is NOT the first sign; absent DTRs is. Oliguria doesn't cause toxicity — it accelerates accumulation of magnesium that's already infusing.

Clinical Pearl

Reflexes, respirations, renal — check all three, in that order, every time. If the knee jerk is gone, the magnesium has gone too far.

Monitoring & Reversal

When a patient is on a magnesium sulfate infusion, nursing monitoring follows the triad: respiratory rate, deep tendon reflexes (DTRs), and urine output. Respirations must stay ≥12 breaths/min — respiratory depression is the earliest directly lethal sign of toxicity. DTRs (typically patellar) must remain present; loss of reflexes is the earliest clinical warning that the serum level is climbing toward danger (usually >9 mg/dL). Urine output must be ≥30 mL/hr because magnesium is renally excreted — oliguria causes rapid accumulation. Therapeutic serum magnesium range is 4–7 mg/dL. Monitoring frequency: vitals and DTRs every 1–2 hours, continuous pulse oximetry, and strict I&O. If toxicity develops (absent DTRs, respirations <12, cardiac arrest), the nurse stops the infusion immediately and administers the antidote: calcium gluconate 1 g IV push over 3 minutes. Calcium gluconate must be kept at the bedside before the infusion even begins — not retrieved from the pharmacy when trouble starts. Fetal monitoring is also continuous because magnesium crosses the placenta; the fetus may show decreased variability and reduced tone at delivery.

Key Distinctions

Don't confuse calcium gluconate (the mag antidote) with calcium chloride — calcium gluconate is the form used in obstetric magnesium reversal because it is less irritating to veins and less likely to cause tissue necrosis. Students often think urine output monitoring is secondary — it is not; impaired renal function is the fastest route to accumulation. Loss of DTRs precedes respiratory arrest; if reflexes are gone, the next domino is breathing.

Clinical Pearl

Before you hang mag, put calcium gluconate at the bedside. Think: 'No reflexes, no respirations, no urine — no more mag.'